Literature DB >> 4142661

Further observations on atypical band keratopathy in glaucoma patients.

R E Kennedy, P D Roca, D S Platt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4142661      PMCID: PMC1311390     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  8 in total

1.  IATROGENIC MERCURIALENTIS.

Authors:  J D ABRAMS
Journal:  Trans Ophthalmol Soc U K       Date:  1963

2.  New treatment for calcific corneal opacities.

Authors:  W M GRANT
Journal:  AMA Arch Ophthalmol       Date:  1952-12

3.  Mercury in the Lens (Hydrargyrosis Lentis).

Authors:  W S Atkinson; L Von Sallmann
Journal:  Trans Am Ophthalmol Soc       Date:  1946

4.  A Colored Reflex from the Anterior Capsule of the Lens Which Occurs in Mercurialism.

Authors:  W S Atkinson
Journal:  Trans Am Ophthalmol Soc       Date:  1942

5.  Mercury content of the human lens.

Authors:  J D Abrams; U Majzoub
Journal:  Br J Ophthalmol       Date:  1970-01       Impact factor: 4.638

Review 6.  Ophthalmic preservatives and vehicles.

Authors:  W Mullen; W Shepherd; J Labovitz
Journal:  Surv Ophthalmol       Date:  1973 May-Jun       Impact factor: 6.048

7.  Atypical band keratopathy in glaucoma patients.

Authors:  R E Kennedy; P D Roca; P H Landers
Journal:  Trans Am Ophthalmol Soc       Date:  1971

8.  Idiopathic band keratopathy.

Authors:  S M Charney
Journal:  Arch Ophthalmol       Date:  1966-04
  8 in total
  3 in total

1.  A clinical pathologic study of mercurialentis medicamentosus.

Authors:  L K Garron; I S Wood; W H Spencer; T L Hayes
Journal:  Trans Am Ophthalmol Soc       Date:  1976

Review 2.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

3.  Atypical band keratopathy following long-term pilocarpine treatment.

Authors:  D J Brazier; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.